These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 11531176)
1. Pemphigus in the southeastern United States. Woldegiorgis S; Swerlick RA South Med J; 2001 Jul; 94(7):694-8. PubMed ID: 11531176 [TBL] [Abstract][Full Text] [Related]
2. Anal involvement in pemphigus vulgaris. Malik M; El Tal AE; Ahmed AR Dis Colon Rectum; 2006 Apr; 49(4):500-6. PubMed ID: 16555033 [TBL] [Abstract][Full Text] [Related]
3. Involvement of the female genital tract in pemphigus vulgaris. Malik M; Ahmed AR Obstet Gynecol; 2005 Nov; 106(5 Pt 1):1005-12. PubMed ID: 16260519 [TBL] [Abstract][Full Text] [Related]
4. A clinical study of patients with pemphigus vulgaris and pemphigus foliaceous: an 11-year retrospective study (1996-2006). Ishii N; Maeyama Y; Karashima T; Nakama T; Kusuhara M; Yasumoto S; Hashimoto T Clin Exp Dermatol; 2008 Aug; 33(5):641-3. PubMed ID: 18627388 [TBL] [Abstract][Full Text] [Related]
5. Pemphigus: analysis of 1209 cases. Chams-Davatchi C; Valikhani M; Daneshpazhooh M; Esmaili N; Balighi K; Hallaji Z; Barzegari M; Akhiani M; Ghodsi Z; Mortazavi H; Naraghi Z Int J Dermatol; 2005 Jun; 44(6):470-6. PubMed ID: 15941433 [TBL] [Abstract][Full Text] [Related]
6. Twelve-year clinico-therapeutic experience in pemphigus: a retrospective study of 54 cases. Mahajan VK; Sharma NL; Sharma RC; Garg G Int J Dermatol; 2005 Oct; 44(10):821-7. PubMed ID: 16207182 [TBL] [Abstract][Full Text] [Related]
7. Value of direct immunofluorescence in predicting remission in pemphigus vulgaris. Balighi K; Taheri A; Mansoori P; Chams C Int J Dermatol; 2006 Nov; 45(11):1308-11. PubMed ID: 17076711 [TBL] [Abstract][Full Text] [Related]
14. Treatment of severe pemphigus with rituximab: report of 12 cases and a review of the literature. Cianchini G; Corona R; Frezzolini A; Ruffelli M; Didona B; Puddu P Arch Dermatol; 2007 Aug; 143(8):1033-8. PubMed ID: 17709662 [TBL] [Abstract][Full Text] [Related]
16. Rituximab in the adjuvant treatment of pemphigus vulgaris: a prospective open-label pilot study in five patients. Goh MS; McCormack C; Dinh HV; Welsh B; Foley P; Prince HM Br J Dermatol; 2007 May; 156(5):990-6. PubMed ID: 17355229 [TBL] [Abstract][Full Text] [Related]
17. Oral lesions in patients with pemphigus vulgaris and bullous pemphigoid. Budimir J; Mihić LL; Situm M; Bulat V; Persić S; Tomljanović-Veselski M Acta Clin Croat; 2008 Mar; 47(1):13-8. PubMed ID: 18714642 [TBL] [Abstract][Full Text] [Related]
18. Fate of pemphigus antibody following successful therapy. Preliminary evaluation of pemphigus antibody determinations to regulate therapy. O'Loughlin S; Goldman GC; Provost TT Arch Dermatol; 1978 Dec; 114(12):1769-72. PubMed ID: 736583 [TBL] [Abstract][Full Text] [Related]
19. Number II. Pemphigus vulgaris. Black M; Mignogna MD; Scully C Oral Dis; 2005 May; 11(3):119-30. PubMed ID: 15888101 [TBL] [Abstract][Full Text] [Related]
20. Dual diagnosis of pemphigus vulgaris and connective tissue disease. Malik M; Ahmed AR J Am Acad Dermatol; 2006 Oct; 55(4):699-704. PubMed ID: 17010755 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]